General Catalyst

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a wide range of technology sectors, including advanced materials, clean energy, disruptive technology, healthcare IT, and consumer services, among others. General Catalyst typically invests between $0.05 million and $0.25 million in seed-stage companies and between $10 million and $50 million in growth equity, seeking profitable firms with substantial revenue and EBITDA. Their approach emphasizes mentorship and collaboration, fostering strong relationships with entrepreneurs who share their vision and values. They have managed eight venture capital funds, accumulating around $3.75 billion in capital commitments, reflecting their commitment to supporting innovative companies throughout their growth journey.

Adrian Abeijon

Investor

Mark Allen

CFO

Juliet Bailin

Principal

Brian Bedol

Managing Director

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Kristen Camarota

Investor

Kenneth Chenault

Chairman and Managing Director

Quentin Clark

Managing Director

Mark Crane

Partner, Investment Team

Joel Cutler

Co-Founder and Managing Director

Christopher Davis

Partner, Investments

Kyle Doherty

Managing Director, Investments

Bill Fitzgerald

Co-Founder and Special Advisors

Molly Blaauw Gillis

Partner and Chief of Staff

Jeremy Goldstein

Partner

Julia Goodman

Investor

Drew Gordon

Investor

Steve Herrod

Managing Director

Tony Ho

Investor

Diana Hong

Investor

Mina Hsiang

Associate

Paula Hübner

Partner

Nmachi Jidenma

Partner

Christopher Kauffman

Principal and Member of the Investment Team

Zak Kukoff

Principal

Bill Kung

Principal

Paul Kwan

Managing Director

Alexandre Momeni

Executive, Investments and Partner

Deep Nishar

Managing Director

Dipchand ("Deep") Nishar

Managing Director

Reva Nohria

Principal

Trevor Oelschig

Managing Director

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Max Rimpel

Partner

Paul Sagan

Investor

Pranav Singhvi

Managing Director

Vedant Suri

Investor

Alex Tran

Managing Director

Catherine Tu

Partner

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Vincent Zhu

Investor

Past deals in Health Diagnostics

Adonis

Series A in 2023
Adonis is the revenue intelligence platform that delivers AI-driven insights to help medical practices, hospitals, or digital health clinic beat revenue KPIs. Adonis is a group of software engineers, data scientists, machine learning enthusiasts, and healthcare experts that is bent on partnering with every healthcare organization across the care continuum to drive intelligence and better decisions.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics operates a biotechnology company that researches on cell therapy development and treatment. It is based in Toronto, Canada.

Doccla

Series A in 2022
Doccla is a provider of virtual ward services that focuses on transitioning patient care from hospitals to home environments. The company partners with healthcare organizations to facilitate early hospital discharges and reduce the likelihood of readmissions by remotely monitoring patients with advanced medical devices. This approach includes onboarding patients at home with necessary monitoring equipment, supported by a mobile team of healthcare professionals who oversee the patient's condition. Once the patient is deemed well enough, the offboarding process commences. Doccla's services were initially developed in response to the Covid-19 pandemic, stemming from a collaborative research project with the NHS and Northampton General Hospital, where they are currently operational.

Redesign Health

Series C in 2022
We’re building consumer health businesses that improve access and elevate patient experience. We partner with entrepreneurs to identify, launch, and scale new businesses. Redesign companies are powered by a growing ecosystem of ideas, capital, talent, and partners, and benefit from our singular focus on consumer health.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

August Health

Series A in 2022
August Health is a high-growth company focused on enhancing the quality of care for older adults living in senior living communities. The company has developed a healthcare platform that collects data to offer insights into the wellness of seniors, facilitating connections to clinical and social support services. This innovative approach aims to help aging individuals reduce their annual long-term care costs while improving their overall well-being. With a background in founding successful ventures and managing extensive engineering and clinical teams, August Health is dedicated to transforming healthcare for vulnerable older adults.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent nurses and lab technicians. Through its telemedicine platform, Examedi allows patients to book diagnostic tests and examinations, including blood tests, pregnancy tests, general checkups, and COVID tests. This service prioritizes accessibility and affordability, ensuring that patients can receive necessary medical care in the comfort of their homes. By coordinating the schedules of healthcare providers with patient needs, Examedi aims to enhance the convenience and efficiency of healthcare delivery.

Flexpa

Seed Round in 2022
Flexpa is a healthcare technology company founded in 2021 and based in San Francisco, California. It specializes in developing a platform that allows digital health applications to connect with patient access APIs and integrate claims histories. By digitizing data collected from various healthcare providers, Flexpa creates analytics dashboards that enable healthcare professionals to track individual and group patient outcomes. This integration of diagnostic tests and lab reports helps providers make informed decisions regarding treatment plans and pharmaceutical options, ultimately aiming to enhance healthcare outcomes.

Orange Health Labs

Series B in 2022
Provider of diagnostic lab services intended to offer affordable home sample collection and test results access. The company's patient-centric approach allows individuals to avoid clinic visits for blood tests, checkups, and pathology services and receive efficient testing, enabling customers to access healthcare services and reducing wait times for test results.

Mirvie

Series B in 2022
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.

Loop

Series B in 2022
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

Eleanor Health

Series C in 2022
Eleanor Health Holdings, LLC is a provider of rehabilitation services focused on addiction and mental health care. Founded in 2019, the company offers comprehensive, evidence-based outpatient care designed to facilitate long-term recovery outcomes. Eleanor Health utilizes a value-based care model, delivering services through a network of outpatient clinics, virtual platforms, and community settings, including patients' homes. Its integrated approach includes medication-assisted treatment, behavioral health support, and personalized recovery plans. In addition to rehabilitation services, the company connects patients with essential resources such as housing, employment, and peer support, ensuring a holistic approach to recovery. Eleanor Health is headquartered in Waltham, Massachusetts.

Alinea Saúde

Venture Round in 2022
Operator of a consumer digital health company designed to a combination of software, technology, and data science to supply consumers with information and access and provide better outcomes and cost-effective decisions. The company offers telehealth services, appointment bookings with the in-network physicians and specialists, enabling patients to have optimized healthcare without changing plans.

Avant-garde Health

Series A in 2022
Avant-garde Health, Inc. is a health care solutions provider focused on delivering value-based payment systems. Founded in 2014 and located in Allston, Massachusetts, the company offers a web-based analytics platform that enables hospitals and physicians to analyze and compare costs and outcomes in care delivery. By empowering healthcare providers with data and insights, Avant-garde Health facilitates the measurement of care process costs and promotes the sharing of treatment-specific information among peer hospitals. This collaborative approach aims to enhance the quality and cost-effectiveness of patient care.

Homeward

Series A in 2022
Homeward is focused on transforming healthcare services for the 60 million Americans residing in rural areas. The company utilizes multidisciplinary care teams that operate both virtually and through mobile care units, ensuring comprehensive and accessible healthcare. Homeward employs in-home remote monitoring technology to enhance patient connections to high-quality and affordable care. By partnering with Medicare Advantage plans, the organization assumes full financial risk for its members, aiming to improve health outcomes while reducing costs. Through these initiatives, Homeward seeks to provide effective support to Medicare-eligible beneficiaries in underserved communities.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtual clinical care software tools aimed at assisting healthcare specialists, particularly neurologists and primary care physicians. The company's platform utilizes data from high-frequency sources to enhance clinical decision-making and improve patient therapy management. By integrating virtual protocols and adaptive machine learning, Story Health empowers clinicians to bridge the gap between clinical evidence and patient realities. Its focus on patient-centered design facilitates a deeper understanding of the physiological effects of diseases and therapies, ultimately aiming to optimize patient care and outcomes in specialty healthcare settings.

Ro

Venture Round in 2022
Ro is a healthcare technology company that offers a comprehensive telehealth platform designed to address a wide range of patient needs, from online diagnosis to the convenient delivery of medication. The company operates three specialized digital health clinics: Roman, which focuses on men's health; Rory, dedicated to women's health; and Zero, aimed at supporting individuals in overcoming addiction. By leveraging technology, Ro enables direct access to physicians, providing high-quality and affordable care tailored to individual circumstances. The platform facilitates personalized treatment options, including free medication delivery, thereby enhancing the overall patient experience and making healthcare more accessible.

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics, Inc. is a Boston-based biotechnology company focused on the research and development of biomolecular condensates to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunology, cardiovascular issues, women's health, and virology. Founded in 2018, the company utilizes a proprietary, AI-powered drug discovery platform that employs machine learning and advanced image analysis to visualize and manipulate biomolecular condensates. This technology aids in identifying novel drug candidates and has applications across various therapeutic areas. Dewpoint Therapeutics collaborates with leading academic and pharmaceutical partners to enhance its research and development efforts, aiming to deliver impactful healthcare solutions.

Jasper Health

Series A in 2022
Jasper Health is a New York-based company founded in 2020 that offers personalized support to cancer patients, ensuring accessibility regardless of income. The company has developed a smart planning application that provides a range of tools and resources at no cost to users. This application includes features such as an auto-create tool for appointment pages, task management, and symptom tracking. Additionally, it helps patients monitor side effects and moods while curating essential product lists. By facilitating organization and enabling activation of support from family and friends, Jasper Health aims to improve the overall experience of individuals navigating cancer treatment.

Casana

Series B in 2022
Casana is a healthcare technology company focused on heart health monitoring. It has developed the Heart Seat, an innovative product that integrates a toilet seat with a cardiovascular monitoring system. This device allows patients to conveniently track essential heart health metrics such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation from the comfort of their homes. The Heart Seat operates on a cloud-connected platform, enabling seamless data capture and analysis. Founded in 2018 and based in Rochester, New York, Casana aims to enhance heart health monitoring by providing a user-friendly solution that minimizes the need for active patient engagement.

Transcarent

Series C in 2022
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.

Well

Series B in 2021
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Ophelia

Series B in 2021
Ophelia Health, Inc. specializes in medication-assisted treatment for individuals struggling with opioid dependence. The company employs a digital platform to facilitate teleconferenced consultations between patients and licensed clinicians, allowing for convenient access to treatment from home. Ophelia provides not only prescription medications but also therapeutic support, aiming to eliminate the stigma often associated with traditional rehabilitation programs. Founded in 2019 and based in Philadelphia, Pennsylvania, Ophelia emphasizes a patient-centered approach that respects individual choices and prioritizes privacy. The organization combines expertise from various fields, including medicine and technology, to deliver evidence-based care and support to those seeking to overcome opioid addiction.

SWORD Health

Series D in 2021
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

Variant Bio

Series B in 2021
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. It was founded in 2018 and headquartered in Seattle, Washington.

Beacon Biosignals

Series A in 2021
Developer of an artificial intelligence-based EEG analysis and diagnosis platform designed to improve human health by providing rapid, targeted interventions through advanced brain analytics. The company's platform can capture real-time brain activity and assist professionals with the study of neurological and psychiatric diseases, enabling healthcare professionals to quantify treatment plans and identify the optimal patient population.

Zerigo Health

Series B in 2021
Zerigo Health, formerly known as Clarify Medical, Inc., specializes in home therapy solutions for chronic skin conditions such as psoriasis, eczema, and vitiligo. The company offers innovative products like the Clarify mobile ultra violet B treatment system and the Home Light Therapy System, both designed to facilitate phototherapy in a home setting. Zerigo Health aims to enhance the ease and effectiveness of UVB therapy through a connected system that allows patients to manage their treatment via a smartphone app. This app enables users to control dosing, frequency, and duration of therapy, ensuring adherence to guidelines set by dermatology experts. By allowing patients to administer their treatments with clinical precision, Zerigo Health improves the overall patient experience, while also monitoring compliance and progress, ultimately empowering individuals to manage their chronic skin conditions more effectively from the comfort of their homes.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Better Health

Series A in 2021
Better Health Supplies is a medical supplier offering an e-commerce experience and service. Better Health provides individuals with chronic conditions with medical supplies from home.

Devoted

Series D in 2021
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Devoted

Series D in 2021
Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Loop

Series A in 2021
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

Orange Health Labs

Series A in 2021
Provider of diagnostic lab services intended to offer affordable home sample collection and test results access. The company's patient-centric approach allows individuals to avoid clinic visits for blood tests, checkups, and pathology services and receive efficient testing, enabling customers to access healthcare services and reducing wait times for test results.

Breathe Well-being

Series A in 2021
Breathe Well-being is a health and wellness company based in India that specializes in managing chronic conditions, particularly diabetes, through a clinically proven program. The platform provides personalized services, including one-on-one coaching, lifestyle tracking, and cognitive behavioral therapy techniques aimed at reducing stress. It focuses on helping users lose weight, lower blood sugar levels, and prevent health complications. With a community-driven approach, Breathe Well-being fosters social interactions through healthy competitions and peer support, enhancing employee engagement and productivity in organizations. The program has successfully assisted over 10,000 members in adopting healthier habits and improving their overall well-being.

Athelas

Series B in 2021
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

OM1

Series D in 2021
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Evvy

Seed Round in 2021
Evvy is a company focused on enhancing female health by providing at-home vaginal microbiome testing. Its mission is to address the gender health gap by identifying and utilizing overlooked biomarkers within the female body, particularly those related to the vaginal microbiome. The testing process employs metagenomic sequencing to analyze individual health symptoms and risks, offering personalized reports that empower women with valuable insights into their bodies. Through this approach, Evvy aims to facilitate better understanding and management of women's health issues.

Aidoc

Series C in 2021
Aidoc is an Israel-based company that specializes in developing artificial intelligence tools for radiologists to enhance the analysis of medical scans. Founded in 2016 and headquartered in Tel Aviv, Aidoc's platform utilizes deep learning and AI algorithms to detect and highlight critical anomalies in medical images and patient data. By deidentifying scans and sending them to its cloud-based system, Aidoc enables real-time identification of acute conditions, thereby improving turnaround time and overall efficiency for radiologists. The company's solutions focus on various medical concerns, including intracranial hemorrhages, spinal fractures, and pulmonary issues such as embolisms and lung nodules. Aidoc aims to streamline the workflow for radiologists, allowing them to concentrate on more complex cases and improve patient outcomes.

SWORD Health

Series C in 2021
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

Transcarent

Series B in 2021
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.

PathAI

Series C in 2021
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

MD Ally

Seed Round in 2021
MD Ally, Inc. is a telemedicine platform focused on enhancing emergency medical services (EMS) through innovative triage solutions. Established in 2020 and headquartered in Philadelphia, Pennsylvania, the company aims to bridge non-emergency care gaps by integrating telemedicine into emergency dispatch processes. This allows EMS personnel to effectively triage patients with non-life-threatening conditions, directing them to virtual medical and behavioral healthcare professionals, as well as follow-up care and social services. MD Ally's platform is designed collaboratively by EMS and emergency room practitioners, making it user-friendly for public safety entities. By providing this technology, MD Ally seeks to improve patient outcomes, reduce response times, and optimize the use of emergency resources, ultimately contributing to better overall healthcare delivery.

Ophelia

Series A in 2021
Ophelia Health, Inc. specializes in medication-assisted treatment for individuals struggling with opioid dependence. The company employs a digital platform to facilitate teleconferenced consultations between patients and licensed clinicians, allowing for convenient access to treatment from home. Ophelia provides not only prescription medications but also therapeutic support, aiming to eliminate the stigma often associated with traditional rehabilitation programs. Founded in 2019 and based in Philadelphia, Pennsylvania, Ophelia emphasizes a patient-centered approach that respects individual choices and prioritizes privacy. The organization combines expertise from various fields, including medicine and technology, to deliver evidence-based care and support to those seeking to overcome opioid addiction.

BrightInsight

Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies. Founded in 2017 and headquartered in San Jose, California, the company provides a global regulated platform designed for building, scaling, and maintaining digital health products and services. BrightInsight's Internet of Things (IoT) platform leverages software and services to capture, transmit, and analyze data from connected medical devices, digital therapeutics, and software as a medical device. By employing a quality management system, the platform supports regulated drugs and devices, enabling customers to enhance patient adherence and engagement through integrated data and actionable insights.

Cityblock

Series C in 2021
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Triomics

Seed Round in 2021
Triomics is a developer of a cloud-based end-to-end platform to automate and accelerate clinical trials.

Ro

Series D in 2021
Ro is a healthcare technology company that offers a comprehensive telehealth platform designed to address a wide range of patient needs, from online diagnosis to the convenient delivery of medication. The company operates three specialized digital health clinics: Roman, which focuses on men's health; Rory, dedicated to women's health; and Zero, aimed at supporting individuals in overcoming addiction. By leveraging technology, Ro enables direct access to physicians, providing high-quality and affordable care tailored to individual circumstances. The platform facilitates personalized treatment options, including free medication delivery, thereby enhancing the overall patient experience and making healthcare more accessible.

ixLayer

Series A in 2021
ixlayer enables leading health systems, clinical labs, biopharma, and consumer companies to offer precision health testing, by remove all the technical, security, and regulatory complexity involved in launching a clinical health test.

Sprinter Health

Seed Round in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Truvian

Series C in 2021
Truvian Sciences Inc is a healthcare company that develops automated diagnostic equipment aimed at providing convenient and affordable health testing services. Based in San Diego, California, and incorporated in 2015, Truvian's technology integrates blood tests, immunoassays, and hematology assays into a single instrument, allowing for lab-accurate results in a shorter timeframe. This innovative approach enables healthcare professionals to access comprehensive and easy-to-understand lab test reports and insights. Additionally, Truvian's software platform facilitates communication between practitioners and patients, enhancing the overall experience of routine health testing.

Circulo

Series A in 2021
Circulo Health is a Medicaid insurance company based in Columbus, Ohio, focused on delivering technology-enabled care to underserved populations. The company operates a medical insurance platform that collaborates with hospitals to provide affordable healthcare services to the sickest and poorest individuals. By leveraging technology, Circulo aims to improve access to proper healthcare for underprivileged communities, ensuring that those in need receive essential medical support.

Casana

Series A in 2021
Casana is a healthcare technology company focused on heart health monitoring. It has developed the Heart Seat, an innovative product that integrates a toilet seat with a cardiovascular monitoring system. This device allows patients to conveniently track essential heart health metrics such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation from the comfort of their homes. The Heart Seat operates on a cloud-connected platform, enabling seamless data capture and analysis. Founded in 2018 and based in Rochester, New York, Casana aims to enhance heart health monitoring by providing a user-friendly solution that minimizes the need for active patient engagement.

Elephant Healthcare

Series A in 2021
Elephant Healthcare Limited, established in 2018 and based in London, United Kingdom, specializes in designing and developing a digital health system. The company focuses on creating a healthcare platform that digitizes clinics and fosters an open, interconnected medical management system. By utilizing blockchain technology and decentralized infrastructure, Elephant Healthcare aims to connect existing healthcare services and facilitate the development of new health applications. This innovative approach is particularly targeted at improving healthcare delivery in low-income countries, enabling hospitals to better serve their patients.

Color

Series D in 2021
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.

Well

Series A in 2020
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

Cityblock

Series C in 2020
Cityblock Health, based in Brooklyn, New York, is a technology-driven healthcare provider focused on serving low-income urban communities with complex needs. Founded in 2017, the company aims to address the unmet health and social needs of Medicaid and Medicare populations through a personalized approach. Cityblock offers primary care, behavioral health, and virtual care services, emphasizing preventive care and mental health support. Its platform integrates communications and information sharing among care teams and members, facilitating better coordination of services. The company also collaborates with community-based organizations to enhance the delivery of care, ultimately seeking to improve health outcomes and reduce costs for its members.

Story Health

Seed Round in 2020
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtual clinical care software tools aimed at assisting healthcare specialists, particularly neurologists and primary care physicians. The company's platform utilizes data from high-frequency sources to enhance clinical decision-making and improve patient therapy management. By integrating virtual protocols and adaptive machine learning, Story Health empowers clinicians to bridge the gap between clinical evidence and patient realities. Its focus on patient-centered design facilitates a deeper understanding of the physiological effects of diseases and therapies, ultimately aiming to optimize patient care and outcomes in specialty healthcare settings.

Transcarent

Series A in 2020
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.

Fractyl Health

Series E in 2020
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Ro

Series C in 2020
Ro is a healthcare technology company that offers a comprehensive telehealth platform designed to address a wide range of patient needs, from online diagnosis to the convenient delivery of medication. The company operates three specialized digital health clinics: Roman, which focuses on men's health; Rory, dedicated to women's health; and Zero, aimed at supporting individuals in overcoming addiction. By leveraging technology, Ro enables direct access to physicians, providing high-quality and affordable care tailored to individual circumstances. The platform facilitates personalized treatment options, including free medication delivery, thereby enhancing the overall patient experience and making healthcare more accessible.

Mindstrong

Series C in 2020
Mindstrong Inc., operating as Mindstrong Health, focuses on remote patient monitoring and mental health symptom assessment through its innovative application. The platform utilizes AI-powered digital biomarker technology to enable users to monitor their mental health symptoms continuously and objectively. Mindstrong offers a range of services, including cognitive behavioral therapy, crisis management, and psychoeducation, delivered through structured messaging sessions. The company develops comprehensive care pathways that integrate passively collected data on cognitive function and mood, enhancing patient engagement through telehealth solutions. Founded in 2013 and based in Mountain View, California, Mindstrong collaborates with various stakeholders, including pharmaceutical companies, healthcare providers, and academic institutions, to advance medical innovation and improve healthcare delivery.

Ophelia

Seed Round in 2020
Ophelia Health, Inc. specializes in medication-assisted treatment for individuals struggling with opioid dependence. The company employs a digital platform to facilitate teleconferenced consultations between patients and licensed clinicians, allowing for convenient access to treatment from home. Ophelia provides not only prescription medications but also therapeutic support, aiming to eliminate the stigma often associated with traditional rehabilitation programs. Founded in 2019 and based in Philadelphia, Pennsylvania, Ophelia emphasizes a patient-centered approach that respects individual choices and prioritizes privacy. The organization combines expertise from various fields, including medicine and technology, to deliver evidence-based care and support to those seeking to overcome opioid addiction.

Karius

Series B in 2020
Karius, Inc. is a life sciences company dedicated to generating genomic insights for infectious diseases. It offers the Karius Test, a non-invasive blood test that utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. Karius also provides laboratory services for pathogen biomarker detection tailored for biopharmaceutical companies. Founded in 2014, the company is based in Redwood City, California, with an additional office in Menlo Park. Its laboratory holds CLIA certification and CAP accreditation, allowing it to conduct high-complexity clinical laboratory testing to support rapid clinical decision-making.

Elysium

Series C in 2019
Elysium Health, Inc. develops and produces health supplements focused on cellular health, long-term brain health, and biological age testing. Founded in 2014 and based in New York, the company sells its products online, aiming to enhance health and longevity through scientifically backed solutions. Elysium collaborates with scientists, clinicians, and health professionals globally to identify and formulate natural compounds. Its flagship product features a proprietary combination of ingredients designed to support overall well-being at the cellular level, addressing contemporary health challenges with a foundation in scientific research.

OM1

Series C in 2019
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Well

Seed Round in 2019
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

PathAI

Series B in 2019
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Mindstrong

Series B in 2018
Mindstrong Inc., operating as Mindstrong Health, focuses on remote patient monitoring and mental health symptom assessment through its innovative application. The platform utilizes AI-powered digital biomarker technology to enable users to monitor their mental health symptoms continuously and objectively. Mindstrong offers a range of services, including cognitive behavioral therapy, crisis management, and psychoeducation, delivered through structured messaging sessions. The company develops comprehensive care pathways that integrate passively collected data on cognitive function and mood, enhancing patient engagement through telehealth solutions. Founded in 2013 and based in Mountain View, California, Mindstrong collaborates with various stakeholders, including pharmaceutical companies, healthcare providers, and academic institutions, to advance medical innovation and improve healthcare delivery.

Spring Science

Series A in 2018
Spring Discovery, Inc. operates a machine learning-based platform focused on accelerating the discovery of therapies for aging and age-related diseases. Based in Palo Alto, California, the company aims to target the biological processes of aging to uncover new treatments for a range of conditions, including cardiovascular and neurodegenerative diseases. By employing innovative computational methods, Spring Discovery enhances experimentation and supports pharmaceutical companies in improving medical treatments for aging-related ailments.

Ro

Series A in 2018
Ro is a healthcare technology company that offers a comprehensive telehealth platform designed to address a wide range of patient needs, from online diagnosis to the convenient delivery of medication. The company operates three specialized digital health clinics: Roman, which focuses on men's health; Rory, dedicated to women's health; and Zero, aimed at supporting individuals in overcoming addiction. By leveraging technology, Ro enables direct access to physicians, providing high-quality and affordable care tailored to individual circumstances. The platform facilitates personalized treatment options, including free medication delivery, thereby enhancing the overall patient experience and making healthcare more accessible.

OM1

Series B in 2018
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Livongo

Series E in 2018
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that offers an integrated suite of solutions aimed at improving the management of chronic conditions. Founded in 2008, Livongo focuses on empowering individuals with conditions such as diabetes, hypertension, and behavioral health issues through real-time data capture and data-driven insights. The company provides cellular-connected devices, supplies, informed coaching, and access to medications, all designed to facilitate health behavior changes. Its product offerings include specialized programs for diabetes, hypertension, prediabetes and weight management, as well as behavioral health support. Livongo's innovative approach combines technology with personalized support, aiming to enhance both clinical outcomes and the overall experience for users and their healthcare teams. As of October 2020, Livongo operates as a subsidiary of Teladoc Health, Inc.

Spring Science

Seed Round in 2018
Spring Discovery, Inc. operates a machine learning-based platform focused on accelerating the discovery of therapies for aging and age-related diseases. Based in Palo Alto, California, the company aims to target the biological processes of aging to uncover new treatments for a range of conditions, including cardiovascular and neurodegenerative diseases. By employing innovative computational methods, Spring Discovery enhances experimentation and supports pharmaceutical companies in improving medical treatments for aging-related ailments.

Avant-garde Health

Seed Round in 2018
Avant-garde Health, Inc. is a health care solutions provider focused on delivering value-based payment systems. Founded in 2014 and located in Allston, Massachusetts, the company offers a web-based analytics platform that enables hospitals and physicians to analyze and compare costs and outcomes in care delivery. By empowering healthcare providers with data and insights, Avant-garde Health facilitates the measurement of care process costs and promotes the sharing of treatment-specific information among peer hospitals. This collaborative approach aims to enhance the quality and cost-effectiveness of patient care.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Ro

Seed Round in 2017
Ro is a healthcare technology company that offers a comprehensive telehealth platform designed to address a wide range of patient needs, from online diagnosis to the convenient delivery of medication. The company operates three specialized digital health clinics: Roman, which focuses on men's health; Rory, dedicated to women's health; and Zero, aimed at supporting individuals in overcoming addiction. By leveraging technology, Ro enables direct access to physicians, providing high-quality and affordable care tailored to individual circumstances. The platform facilitates personalized treatment options, including free medication delivery, thereby enhancing the overall patient experience and making healthcare more accessible.

PathAI

Series A in 2017
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Color

Series C in 2017
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.

OM1

Series A in 2017
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Livongo

Series D in 2017
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that offers an integrated suite of solutions aimed at improving the management of chronic conditions. Founded in 2008, Livongo focuses on empowering individuals with conditions such as diabetes, hypertension, and behavioral health issues through real-time data capture and data-driven insights. The company provides cellular-connected devices, supplies, informed coaching, and access to medications, all designed to facilitate health behavior changes. Its product offerings include specialized programs for diabetes, hypertension, prediabetes and weight management, as well as behavioral health support. Livongo's innovative approach combines technology with personalized support, aiming to enhance both clinical outcomes and the overall experience for users and their healthcare teams. As of October 2020, Livongo operates as a subsidiary of Teladoc Health, Inc.

PatientBank

Seed Round in 2016
PatientBank offers an online platform that facilitates the requesting, storage, and sharing of medical records. This service enables patients to gather their medical information from various healthcare providers, including doctors and hospitals, and share it with family members or other care providers as needed. By streamlining the process of accessing and managing medical records, PatientBank aims to enhance the communication between patients and healthcare professionals, ultimately supporting better health management and checkups.

Elysium

Series B in 2016
Elysium Health, Inc. develops and produces health supplements focused on cellular health, long-term brain health, and biological age testing. Founded in 2014 and based in New York, the company sells its products online, aiming to enhance health and longevity through scientifically backed solutions. Elysium collaborates with scientists, clinicians, and health professionals globally to identify and formulate natural compounds. Its flagship product features a proprietary combination of ingredients designed to support overall well-being at the cellular level, addressing contemporary health challenges with a foundation in scientific research.

Color

Series B in 2016
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.

TearScience

Series D in 2016
TearScience, Inc. is a medical device company that engages in identifying, diagnosing, and treating meibomian gland disease (MGD), which is the cause of dry eye. The company focuses on the early detection and treatment of prevalent, chronic, and progressive MGD. It develops LipiFlow Activator, a single-use sterile device that delivers automated therapeutic energies to each meibomian gland while protecting the delicate structures of the patient’s eye; and LipiScan, a gland imager that allows eye care professionals to evaluate meibomian glands in practices. The company was formerly known as Kolis Scientific, Inc. and changed its name to TearScience, Inc. in July 2005. TearScience, Inc. was founded in 2005 and is based in Morrisville, North Carolina. As of September 6, 2017, TearScience, Inc. operates as a subsidiary of Johnson & Johnson Surgical Vision, Inc.

Livongo

Series C in 2016
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that offers an integrated suite of solutions aimed at improving the management of chronic conditions. Founded in 2008, Livongo focuses on empowering individuals with conditions such as diabetes, hypertension, and behavioral health issues through real-time data capture and data-driven insights. The company provides cellular-connected devices, supplies, informed coaching, and access to medications, all designed to facilitate health behavior changes. Its product offerings include specialized programs for diabetes, hypertension, prediabetes and weight management, as well as behavioral health support. Livongo's innovative approach combines technology with personalized support, aiming to enhance both clinical outcomes and the overall experience for users and their healthcare teams. As of October 2020, Livongo operates as a subsidiary of Teladoc Health, Inc.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Corvia

Series D in 2015
Corvia Medical, Inc. is a medical device company specializing in the development of structural heart devices aimed at treating heart failure. The company's primary innovation is the InterAtrial Shunt Device (IASD), a transcatheter device designed to address diastolic heart failure (DHF), also referred to as heart failure with preserved ejection fraction (HFpEF). The IASD system works by creating a small opening between the left and right atria, which helps to lower elevated left atrial pressure, a main contributor to DHF symptoms. Founded in 2009 and based in Andover, Massachusetts, Corvia Medical was previously known as DC Devices Inc. and rebranded in June 2015. Through its innovative approach, the company aims to alleviate symptoms and enhance the quality of life for patients affected by heart failure.

Livongo

Series B in 2015
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that offers an integrated suite of solutions aimed at improving the management of chronic conditions. Founded in 2008, Livongo focuses on empowering individuals with conditions such as diabetes, hypertension, and behavioral health issues through real-time data capture and data-driven insights. The company provides cellular-connected devices, supplies, informed coaching, and access to medications, all designed to facilitate health behavior changes. Its product offerings include specialized programs for diabetes, hypertension, prediabetes and weight management, as well as behavioral health support. Livongo's innovative approach combines technology with personalized support, aiming to enhance both clinical outcomes and the overall experience for users and their healthcare teams. As of October 2020, Livongo operates as a subsidiary of Teladoc Health, Inc.

Livongo

Series A in 2014
Livongo Health, Inc. is a consumer digital health company based in Mountain View, California, that offers an integrated suite of solutions aimed at improving the management of chronic conditions. Founded in 2008, Livongo focuses on empowering individuals with conditions such as diabetes, hypertension, and behavioral health issues through real-time data capture and data-driven insights. The company provides cellular-connected devices, supplies, informed coaching, and access to medications, all designed to facilitate health behavior changes. Its product offerings include specialized programs for diabetes, hypertension, prediabetes and weight management, as well as behavioral health support. Livongo's innovative approach combines technology with personalized support, aiming to enhance both clinical outcomes and the overall experience for users and their healthcare teams. As of October 2020, Livongo operates as a subsidiary of Teladoc Health, Inc.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Corvia

Series D in 2014
Corvia Medical, Inc. is a medical device company specializing in the development of structural heart devices aimed at treating heart failure. The company's primary innovation is the InterAtrial Shunt Device (IASD), a transcatheter device designed to address diastolic heart failure (DHF), also referred to as heart failure with preserved ejection fraction (HFpEF). The IASD system works by creating a small opening between the left and right atria, which helps to lower elevated left atrial pressure, a main contributor to DHF symptoms. Founded in 2009 and based in Andover, Massachusetts, Corvia Medical was previously known as DC Devices Inc. and rebranded in June 2015. Through its innovative approach, the company aims to alleviate symptoms and enhance the quality of life for patients affected by heart failure.

Corvia

Series C in 2013
Corvia Medical, Inc. is a medical device company specializing in the development of structural heart devices aimed at treating heart failure. The company's primary innovation is the InterAtrial Shunt Device (IASD), a transcatheter device designed to address diastolic heart failure (DHF), also referred to as heart failure with preserved ejection fraction (HFpEF). The IASD system works by creating a small opening between the left and right atria, which helps to lower elevated left atrial pressure, a main contributor to DHF symptoms. Founded in 2009 and based in Andover, Massachusetts, Corvia Medical was previously known as DC Devices Inc. and rebranded in June 2015. Through its innovative approach, the company aims to alleviate symptoms and enhance the quality of life for patients affected by heart failure.

Oceans Healthcare

Venture Round in 2013
Oceans Healthcare is a prominent behavioral health provider established in 2004, specializing in the treatment of older adults and seniors. The organization offers both inpatient and outpatient services, addressing various mental health conditions, including depression, anxiety, and schizophrenia, as well as behavioral changes associated with medication management and substance abuse. With 17 hospital locations in Texas and Louisiana, Oceans Healthcare is recognized as the largest provider of inpatient geriatric behavioral health treatment in Louisiana and one of the largest in Texas. The company is committed to expanding access to care for older adults by enhancing its service offerings, which now include military-focused outpatient programs and treatment options for substance use disorders.

SynapDx

Series B in 2012
SynapDx is a laboratory services company focused on developing blood tests aimed at the early identification of children at risk for autism spectrum disorders (ASDs). Founded by Stanley Lapidus and headquartered in Lexington, Massachusetts, the company collaborates with experts in ASD and gene expression from leading institutions to enhance the effectiveness of its diagnostic tests. With the aim of enabling earlier detection, SynapDx serves physicians evaluating children for developmental disorders, addressing a critical need as autism is estimated to affect 1 in 110 children in the United States. The company secured initial venture funding in 2010, which has supported its mission to improve diagnostic capabilities for ASDs.

Humedica

Venture Round in 2012
Humedica is the clinical intelligence company that powers health care providers and life sciences organ izations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.

Humedica

Venture Round in 2011
Humedica is the clinical intelligence company that powers health care providers and life sciences organ izations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.

DrChrono

Seed Round in 2011
DrChrono Inc. is a healthcare technology company based in Sunnyvale, California, founded in 2009 by Daniel Kivatinos and Michael Nusimow. The company provides an integrated electronic health record (EHR) platform designed for physicians and healthcare practices. Its offerings include cloud-based scheduling, clinical documentation, a patient portal, billing software, and revenue cycle management services. DrChrono aims to alleviate the administrative burdens faced by healthcare providers, allowing them to focus more on patient care. Additionally, the company has developed a telehealth platform to facilitate remote healthcare services, catering to the needs of both providers and consumers. By creating an all-in-one solution, DrChrono supports independent practices in navigating the complexities of today's healthcare environment.

DrChrono

Seed Round in 2011
DrChrono Inc. is a healthcare technology company based in Sunnyvale, California, founded in 2009 by Daniel Kivatinos and Michael Nusimow. The company provides an integrated electronic health record (EHR) platform designed for physicians and healthcare practices. Its offerings include cloud-based scheduling, clinical documentation, a patient portal, billing software, and revenue cycle management services. DrChrono aims to alleviate the administrative burdens faced by healthcare providers, allowing them to focus more on patient care. Additionally, the company has developed a telehealth platform to facilitate remote healthcare services, catering to the needs of both providers and consumers. By creating an all-in-one solution, DrChrono supports independent practices in navigating the complexities of today's healthcare environment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.